Skip to main content

Advertisement

Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature

Article metrics

  • 96 Accesses

The original article was published in Journal for ImmunoTherapy of Cancer 2019 7:266

Correction to: J ImmunoTher Cancer (2019) 7:266

https://doi.org/10.1186/s40425-019-0760-4

Following publication of the original article [1], the authors reported that authors’ given and family names haven been incorrectly tagged.

Below the authors’ name correctly tagged.

Given name: Anastasia

Family name: Saade

Given name: Audrey

Family name: Mansuet-Lupo

Given name: Jennifer

Family name: Arrondeau

Given name: Constance

Family name: Thibault

Given name: Mariana

Family name: Mirabel

Given name: François

Family name: Goldwasser

Given name: Stéphane

Family name: Oudard

Given name: Laurence

Family name: Weiss

The corrections have been implemented in the original article as well.

Reference

  1. 1.

    Anastasia, et al. Pericardial effusion under nivolumab: case-reports and review of the literature. J ImmunoTher Cancer. 2019;7:266. https://doi.org/10.1186/s40425-019-0760-4.

Download references

Author information

Correspondence to Laurence Weiss.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Saade, A., Mansuet-Lupo, A., Arrondeau, J. et al. Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature. j. immunotherapy cancer 7, 335 (2019) doi:10.1186/s40425-019-0822-7

Download citation